Dow Up0.51% Nasdaq Up0.24%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
8.79 Down 0.19(2.12%) 4:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development6,107  7,450  7,325  5,780  
Selling General and Administrative1,277  1,256  1,226  1,365  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (7,384) (8,706) (8,551) (7,145)
Income from Continuing Operations
Total Other Income/Expenses Net2  3  2  3  
Earnings Before Interest And Taxes(7,382)(8,703)(8,549)(7,142)
Interest Expense -   -   -   -  
Income Before Tax(7,382)(8,703)(8,549)(7,142)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(7,382)(8,703)(8,549)(7,142)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (7,382) (8,703) (8,549) (7,142)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (7,382) (8,703) (8,549) (7,142)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.